Bring your biosimilar to market faster.
Expert-led decision support
It is challenging to navigate biosimilars regulation and the payer landscape, provide real world evidence to physicians, and compete for the right sites and patients. IQVIA can help you overcome these obstacles and make better decisions throughout your study's lifecycle using a customized approach backed by expertise in more than 13 therapeutic areas.
It starts when you leverage the power of the IQVIA Connected Intelligence™. This is how we use unparalleled data, transformative technology, advanced analytics, and scientific expertise to help achieve study goals and bring biosimilar drugs to market faster.
The power of IQVIA Connected Intelligence™
- Experts that have built trial designs for more than a dozen compounds over the past decade, reaching 20 unique biological targets
- Transformative technology that allows real-time access to operation-critical information to accelerate study timelines
- Unparalleled data sources available to optimize biosimilar drug development
- Advanced analytics capabilities to identify the right sites – inclusive of established site relationships – allowing for faster start-up and accelerated patient enrollment
IQVIA Integrated Biosimilar Offerings
Customizable scope of solutions to meet your study needs
Considerations for clinical trials of anti-VEGF biosimilars in a crowded landscape